tirzepatide protocol I'm starting a new longevity protocol: microdosing Tirzepatide, a dual GLP-1/GIP receptor agonist. Here is the existing evidence, my protocol, measurement plan, and what I expect to achieve by this intervention. 🧵 Tirzepatide (60mg Vial) Dosage Protocol

For broader context on aging biology and metabolic decline research, the NIH National Institute on Aging provides authoritative resources on the metabolic changes and epigenetic mechanisms that underlie age-associated obesity and sarcopenia

The Cons of Microdosing GLP-1s The reason they dont is that we dont have any data on it, YET

Lower risks associated with chronic conditions, such as diabetes and hypertension, which are often linked to obesity

The Bioavailability Revolution from WBCIL Introduction The Antioxidant Paradox You spend money on your health

Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care

Bentuk topikal ini bekerja pada lapisan luar kulit untuk memberikan efek pencerahan dan antioksidan